xAnts

Perugia's hospital network (Azienda Ospedaliera di Perugia) has implemented a new, advanced technology for breast cancer diagnosis: contrast-enhanced mammography. The procedure, now operational, represents a significant advancement in early detection and diagnostic accuracy for women in the Umbria region.

Contrast-enhanced mammography builds upon traditional mammography by utilizing a contrast agent injected intravenously. This agent highlights areas of increased blood flow, which can be indicative of cancerous tissue. This technique is particularly valuable in cases where standard mammograms yield inconclusive results or in women with dense breast tissue, where tumors can be harder to detect.

The introduction of this technology aims to improve the detection rate of breast cancer, especially in its early stages, leading to better treatment outcomes. Early detection is crucial for successful breast cancer treatment, and this new method offers a more sensitive and precise diagnostic tool for healthcare professionals. The hospital administration has emphasized their commitment to providing patients with access to the latest medical advancements.

The implementation of contrast-enhanced mammography at the Azienda Ospedaliera di Perugia reflects a broader trend in medical innovation aimed at improving the accuracy and efficiency of cancer screening. Further details regarding appointment scheduling and patient eligibility for the procedure are expected to be released by the hospital shortly.